Testing effectiveness (Phase 2)Study completedNCT02597322
What this trial is testing
Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)
Who this might be right for
cT2a N0NxM0 Renal Tumor
Assistance Publique - Hôpitaux de Paris 21